Company: CRNX
Filing Date: 2025-04-23
Form Type: DEF 14A
Source: 0000950170-25-057452
Chunk: 38

Company: Crinetics Pharmaceuticals, Inc.
Filing Date: 2025-04-23
Form: DEF 14A
Chunk 38
---
, (iii) 1,000 shares of common stock held directly by Dr. Struthers’ spouse and (iv) 1,145,460 shares of common stock underlying options held by Dr. Struthers that are exercisable as of April 14, 2025 or that will become exercisable within 60 days after such date.

Mr. Wilson ceased serving as the Chief Financial Officer of the Company, effective February 28, 2025, after which he remained with the Company as an employee to assist with the transition of his duties to the Company’s current Chief Financial Officer, Tobin “Toby” Schilke, through April 1, 2025. Includes 105,237 shares of common stock held by Mr. Wilson as of April 1, 2025.

Includes 87,491 shares of common stock and 195,131 shares of common stock underlying options held by Mr. Knight that are exercisable as of April 14, 2025 or that will become exercisable within 60 days after such date.

Includes 108,588 shares of common stock and 642,222 shares of common stock underlying options held by Dr. Betz that are exercisable as of April 14, 2025 or that will become exercisable within 60 days after such date.

Includes 72,233 shares of common stock and 82,936 shares of common stock underlying options held by Dr. Pizzuti that are exercisable as of April 14, 2025 or that will become exercisable within 60 days after such date.

Includes 9,400 shares of common stock and 93,400 shares of common stock underlying options held by Dr. Bedrosian that are exercisable as of April 14, 2025 or that will become exercisable within 60 days after such date.

Includes 21,936 shares of common stock and 45,492 shares of common stock underlying options held by Mr. Fust that are exercisable as of April 14, 2025 or that will become exercisable within 60 days after such date.

Includes 9,400 shares of common stock and 93,400 shares of common stock underlying options held by Dr. Nichols that are exercisable as of April 14, 2025 or that will become exercisable within 60 days after such date.

Includes 9,400 shares of common stock and 88,400 shares of common stock underlying options held by Ms. Okey that are exerc